Open and laparoscopic surgeries are associated with comparable 90 day morbidities and mortalities following ERAS protocols- A retrospective Study.

Introduction: Aim of study to evaluate 90 days mortality and morbidity after ERAS protocol and also weather there is any difference in morbidity and mortality between Open and Laparoscopic surgeries. Material and Methods: All the gastrointestinal surgeries performed between April 2016 to march 2019 in our institution have been analysed for morbidity and mortality after ERAS protocols and data was collected prospectively. Results: We performed 245 gastrointestinal and hepato-biliary surgeries between April 2016 to march 2019. Mean age of patients was 50.96 years. 135 were open surgeries and 110 were laparoscopic surgeries. Mean ASA score was 2.40, mean operative time was 111 minutes, mean CDC grade of surgery was 2.56. 40 were emergency surgeries and 205 were elective surgeries. Overall 90 days mortality rate was 8.5% and over all morbidity rate was around 9.79% . On univariate analysis morbidity was associated significantly with higher CDC grade of surgeries, higher ASA grade, more operative time, more blood products use, more hospitalstay, open surgeries,HPB surgeries and luminal surgeries(non hpb gastrointestinal surgeries) were associated with higher 90 days morbidity. On multivariate analysis no factors independently predicted morbidity. On univariate analysis 90 days mortality was predicted by grade of surgeries, higher ASA grade, more operative time, more blood products use, open surgeries and emergency surgeries. However on multivariate analysis only more blood products used was independently associated with mortality Conclusion: There is no difference between 90 day mortality and moribidity rates between open and laparoscopic surgeries.

significantly with higher CDC grade of surgeries, higher ASA grade, more operative time, more blood products use, more hospitalstay, open surgeries,HPB surgeries and luminal surgeries(non hpb gastrointestinal surgeries) were associated with higher 90 days morbidity. On multivariate analysis no factors independently predicted morbidity. On univariate analysis 90 days mortality was predicted by grade of surgeries, higher ASA grade, more operative time, more blood products use, open surgeries and emergency surgeries. However on multivariate analysis only more blood products used was independently associated with mortality Conclusion: There is no difference between 90 day mortality and moribidity rates between open and laparoscopic surgeries.

Introduction:
Early recovery after surgery (ERAS) protocol is becoming gold standard in peri operative care with excellent results in colorectal, gastric and HPB surgeries. 1 ERAS is a evidence based peri-operative protocol which has shown significant improvements in perioperative outcomes. 2 Despite these overwhelming evidences . CC-BY 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
is the (which was not peer-reviewed) The copyright holder for this preprint . https: //doi.org/10.1101//doi.org/10. /2020 implementation of these protocols has been very slow and lack wide spread approval. 3 ERAS has initially developed for colorectal surgeries 4 , However its implementation is being tested in all the other fields. 4 It is difficult to have a common ERAS protocol across all subspecialties of GI surgery, hence there are not many papers We evaluated perioperative outcomes after ERAS protocols in our data which includes Upper gastrointestinal, HPB, colorectal and laparoscopic as well as open surgeries.
Laparoscopic gastrointestinal surgeries have significantly reduced peri-operiative morbidity and mortalities. 5 However many of these studies were done before ERAS era. Very few studies have compared laparoscopic vs open gastrointestinal surgeries after ERAS protocols.
Aims of study were to evaluate morbidity and mortality rates following ERAS protocol and if there is any difference in perioperative outcomes in morbidity and mortality between Open and Laparoscopic surgeries.

Materials and Methods:
All the gastrointestinal and HPB surgeries performed between April 2016 to march 2019 in our institution have been analysed prospectively for morbidity and mortality after ERAS protocols. Morbidity was defined as any grade of complications according to clavien-dindo classification. 6 We also evaluated factors responsible for . CC-BY 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
is the (which was not peer-reviewed) The copyright holder for this preprint Overall 90 days mortality rate was 8.5% and over all morbidity rate was around 9.79% . 90 days mortality and morbidity in elective surgeries was 4.08% and 8.16% respectively.
On univariate analysis 90 days morbidity was significantly with higher CDC grade of surgeries, higher ASA grade, more operative time, more blood products use, more hospital stay and HPB and luminal surgeries were associated with higher 90 days morbidity. [ Table 2]. On multivariate analysis no factor independently predicted morbidity.
On univariate analysis 90 days mortality was predicted by grade of surgeries, higher ASA grade, more operative time, more blood products use, open surgeries and emergency surgeries. [ Table 3]However on multivariate analysis number of blood product used independently predicted mortality. (p= 0.046, odds ratio 1.52,95 percent C.I. 1.008-2.317).
. CC-BY 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
is the (which was not peer-reviewed) The copyright holder for this preprint . https://doi.org/10. 1101/2020 We also did univariate and multivariate analysis of different factors between open and laparoscopic groups.
In univariate analysis open surgeries were associated with increased morbidity and mortality ,However on multivariate analysis open surgery did not independently predicted morbidity.
However ,multivariate analysis showed there is significantly increased operative time and hospital stay in open surgeries . [ Table 4] To, confirm our findings apart from logistic regression we also did multivariate cox regression analysis of 90 day survivals which showed, only less operative time, less hospital stay and less blood products independently predicted 90 days survival.
We also did same thing for 90 days morbidity free survival, which showed no factor independently predicted morbidity free survival after cox regression multivariate analysis.
We also prepared 90 days morbidity free and over all survival curves for open and laparoscopic surgeries.[figure1,2], Which did not show statistical significance on cox multivariate analysis.

Discussion:
Enhanced recovery after surgery though initially described for colorectal surgery is now becoming standard protocol for all surgeries and it has significantly reduced hospital stay and cost without affecting morbidity and mortality. [1][2][3][4][5] . CC-BY 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
is the (which was not peer-reviewed) The copyright holder for this preprint . https://doi.org/10. 1101/2020 However, there are very few studies available for studying effect of ERAS protocols on morbidity and mortality in entire cohort including HPB and Gastrointestinal surgeries.
We follow ERAS protocols for every gastrointestinal and HPB surgeries as shown in table 1 so we evaluated 90 days morbidity and mortality in our series after implementing ERAS protocols and also studied various factor affecting 90 days morbidity and mortality.
We also evaluated difference in morbidity and mortality in laparoscopic vs open surgery group after implementing ERAS protocol.
In our series Overall 90 days mortality rate was 8.5% and over all morbidity rate was around 9.79%. 90 days mortality and morbidity in elective surgery was around 4.08 and 8.16 percent respectively. Mortality is defined as any death within 90 days post operative period and morbidity included clavien-dindo grade 3 and grade 4 complications, which is similar to published data. 9,10 In our study in univariate analysis morbidity was associated significantly with higher CDC grade of surgeries, higher ASA grade, more operative time, more blood products use, more hospital stay, open surgeries,HPB surgeries and luminal surgeries(non hpb gastrointestinal surgeries) were associated with higher 90 days morbidity However on multivariate analysis no factors independently predicted morbidity.
Similarly in mortality analysis univariate analysis 90 days mortality was predicted by grade of surgeries, higher ASA grade, more operative time, more blood products use, open surgeries and emergency surgeries and on multivariate analysis only more blood products used was independently associated with mortality. These data shows . CC-BY 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
is the (which was not peer-reviewed) The copyright holder for this preprint . https://doi.org/10. 1101/2020 laparoscopic or open surgeries did not predicted 90 days morbidity and mortalities independently.
Thus, 90 days morbidity and mortality analysis in our series shows patient and disease related factors. Which is also shown in various published studies. 11.12.13 One of the main aims of our study was to evaluate 90 morbidity and mortality difference between open and laparoscopic surgeries after implementing ERAS protocol.
Various study published showed that morbidity after colorectal surgeries were less with similar mortalities after colorectal surgeries. 14,15 In case of cholecystectomy it is now concluded that laparoscopic surgery reduces morbidity. 16 However, all these were before wide spread use of ERAS protocol. Our study being a retrospective study has inherent biases of retrospective study, and further randomised control trials are needed to confirm our findings. Also although primary aim of study to evaluate effect of ERAS protocol in heterogenous . CC-BY 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
is the (which was not peer-reviewed) The copyright holder for this preprint . https://doi.org/10.1101/2020.04.08.20057521 doi: medRxiv preprint populations, more data in each specific subgroups are needed and we are in process of evaluating the same.
In conclusion there is no difference in 90 days morbidity and mortality between open and laparoscopic surgeries after implementing ERAS protocols and morbidity and mortality is associated with patient and disease related factors. author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
is the (which was not peer-reviewed) The copyright holder for this preprint . https: //doi.org/10.1101//doi.org/10. /2020 Laparoscopic versus open colorectal surgery within enhanced recovery after surgery programs: a systematic review and meta-analysis of randomized controlled trials. Surg Endosc. 2015 Aug;29 (8) Table :3 Univariate and multivariate analysis of 90 day mortality.
. CC-BY 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
is the (which was not peer-reviewed) The copyright holder for this preprint . https://doi.org/10.1101/2020.04.08.20057521 doi: medRxiv preprint CC-BY 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
is the (which was not peer-reviewed) The copyright holder for this preprint . https://doi.org/10.1101/2020.04.08.20057521 doi: medRxiv preprint . CC-BY 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
is the (which was not peer-reviewed) The copyright holder for this preprint . https://doi.org/10.1101/2020.04.08.20057521 doi: medRxiv preprint . CC-BY 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
is the (which was not peer-reviewed) The copyright holder for this preprint . https://doi.org/10. 1101/2020